EP2691112
Stöðugar samsetningar á mótefnum gegn PD-1 stýrðum frumudauðaviðtaka í mönnum og tengd meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.3.2012EP published:
23.5.2018EP application number:
12763896.3
EP translation filed:
15.6.2018Grant published:
15.7.2018EPO information:
European Patent Register
Max expiry date:
28.3.2032Expiry date:
28.3.2027Next due date:
31.3.2027
Title:
STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS
Timeline
Today
29.3.2012EP application
23.5.2018EP Publication
15.6.2018Translation submitted
15.7.2018Registration published
28.3.2027Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
SHARMA, Manoj K.Address:
Summit, NJ, US
Name:
NARASIMHAN, Chakravarthy NachuAddress:
Summit, NJ, US
Name:
GERGICH, Kevin JamesAddress:
North Wales, PA, US
Name:
KANG, Soonmo PeterAddress:
Rahway, NJ, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161470121 PDate:
31.3.2011Country:
US
Classification
Categories:
A61K 39/395, A61K 9/19, A61K 9/00, A61K 47/18, A61K 47/26, C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 14.2.2019
Expires: 28.3.2020
Payer: Örn Þór, slf.
Number: 9
Paid: 14.2.2020
Expires: 28.3.2021
Payer: Örn Þór slf.
Number: 10
Paid: 10.2.2021
Expires: 28.3.2022
Payer: Örn Þór slf.
Number: 11
Paid: 15.2.2022
Expires: 28.3.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 12.2.2023
Expires: 28.3.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.2.2024
Expires: 28.3.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 29.1.2025
Expires: 28.3.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.3.2026
Expires: 28.3.2027
Payer: Árnason Faktor ehf.